Clinical Trials Update: April 22, 2009

Posted: April 22, 2009

Gastroesophageal Reflux Disease (GERD)
Migraine and Cluster Headaches
Pain
Irritable Bowel Syndrome (IBS)
Psoriasis
Atopic Dermatitis (Eczema)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Gastroesophageal Reflux Disease (GERD)

If you are 18 to 75 with a history of GERD symptoms (e.g., acid regurgitation, dyspepsia, chest or gastric pain) for at least three months, you may qualify for this study.

The research site is in Nashville, Tenn.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=70.

-----

Migraine and Cluster Headaches

If you are an adult with a history of chronic migraine for at least six months and are not taking any daily medication to prevent migraines other than topiramate (Topamax), you may qualify for this study evaluating two FDA-approved medications.

The research site is in Irvine, Calif.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=100.

-----

Pain

If you have painful osteoarthritis of the hip or knee and are taking naproxen or celecoxib, you may qualify for this study.

The research site is in Raleigh, N.C.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=834.

-----

Irritable Bowel Syndrome (IBS)

This study will evaluate an FDA-approved drug for people with non-constipation IBS. It will include eight clinic visits over 14 weeks.